Glucagon-Like Peptide-1 Receptor Agonist Ameliorates 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Neurotoxicity Through Enhancing Mitophagy Flux and Reducing -Synuclein and Oxidative Stress
Research applications have expanded to encompass investigations of ghrelin receptor pharmacology, selective signaling pathway activation, and synergistic interactions with GHRH analogs
The advanced protocol should only be implemented after successful tolerance of lower doses and under appropriate medical supervision
The association between mortality and male infertility: systematic review and meta-analysis
Both produce significant weight loss
In this six-month prospective cohort study, 200 adults ages 18 to 65 with a BMI of 25 kg/m or higher (classified as overweight or obese) were enrolled and prescribed either the GLP-1 receptor agonist semaglutide or the dual GLP-1/GIP agonist tirzepatide